| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5dfc0b033ac4c841466d97a5f28ea32b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate |
1996-08-08^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3533ae268f20ee5bb3c5130d5080f95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cec8548863146e43d9a16ecbc5a384f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb9744175f467597026b1882b6240f8f |
| publicationDate |
2003-04-23^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0856315-A4 |
| titleOfInvention |
DRUG |
| abstract |
The present invention relates to an antitumor or anti-AIDS composition containing a protein-farnesyltransferase inhibitor and an agent which decreases farnesyl pyrophosphate in vivo as active ingredients. |
| priorityDate |
1995-08-09^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |